Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$9.67 -0.82%
Market Cap
$143.2M
Price Target
Refer to Report
Volume
19.2K
52wk Range
$7.65 - $38.4
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).